Poole Jonathan has filed 4 insider transactions across 1 company since March 2026.
Most recent transaction: a grant/award of 7482 shares of ACADIA PHARMACEUTICALS INC ($ACAD) on March 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Poole Jonathan | Not found | A | Director Stock Options (Right to Buy) | 7482 | $0.00 | 7,482.0000 | 170,650,000 | 9999.99% | 0.00% |
| March 3, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Poole Jonathan | Not found | A | Director Stock Options (Right to Buy) | 3565 | $0.00 | 3,565.0000 | 170,650,000 | 9999.99% | 0.00% |
| March 3, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Poole Jonathan | Not found | A | Restricted Stock Units | 4218 | $0.00 | 4,218.0000 | 170,650,000 | 9999.99% | 0.00% |
| March 3, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Poole Jonathan | Not found | A | Restricted Stock Units | 2010 | $0.00 | 2,010.0000 | 170,650,000 | 9999.99% | 0.00% |